Back to top
more

The Campbell's Company (CPB)

(Delayed Data from NSDQ)

$30.74 USD

30.74
5,955,172

+0.68 (2.26%)

Updated Nov 7, 2025 04:00 PM ET

After-Market: $30.74 0.00 (0.00%) 5:14 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.63%
2Buy17.80%
3Hold9.42%
4Sell5.10%
5Strong Sell2.04%
S&P50010.70%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 28% (174 out of 252)

Industry: Food - Miscellaneous

Zacks News

Zacks Equity Research

Nomad Foods (NOMD) Surpasses Q3 Earnings and Revenue Estimates

Nomad Foods (NOMD) delivered earnings and revenue surprises of +3.64% and +0.01%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Flowers Foods Set to Release Q3 Earnings: Key Insights for Investors

FLO's third-quarter results are likely to show revenue growth from branded retail strength, though earnings may fall on softer volumes.

Zacks Equity Research

Nu Skin to Report Q3 Earnings: What's in the Cards for NUS Stock?

NUS' Q3 results may reflect revenue pressure, but cost savings and efficiency gains are likely to have helped sustain earnings.

Zacks Equity Research

Arko's Q3 Earnings on Deck: Key Factors You Should Understand

ARKO's third-quarter results are likely to reflect softer sales and fuel volumes, partly offset by margin discipline and targeted initiatives.

Zacks Equity Research

Monster Beverage Gears Up for Q3 Earnings: Here's What You Should Know

MNST's Q3 results are likely to show double-digit revenue and earnings growth, fueled by innovation, pricing gains and global expansion momentum.

Zacks Equity Research

Why Campbell (CPB) is Poised to Beat Earnings Estimates Again

Campbell (CPB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Equity Research

e.l.f. Beauty to Report Q2 Earnings: What Awaits ELF Stock?

ELF's upcoming results hinge on Rhode's premium skincare boost, rising sales momentum, and ongoing tariff and cost pressures.

Zacks Equity Research

Coty Q1 Earnings on Deck: Key Factors You Should Understand

COTY's fiscal first-quarter results are likely to reflect retailer destocking and tariff headwinds, partly offset by prestige and cost-saving initiatives.

Zacks Equity Research

B&G Foods' Q3 Earnings in the Cards: What Awaits BGS Stock?

B&G Foods faces weak sales and cost pressures, but its productivity and portfolio efforts may soften the blow ahead of results.

Zacks Equity Research

AB InBev Q3 Earnings Preview: Will Pricing Offset Volume Pressures?

BUD's Q3 results are expected to show pricing strength and premiumization gains. Yet, volume softness and cost pressures are likely to have weighed on its performance.

Zacks Equity Research

Will Campbell's PEAK Savings Program Lift Margins by 2028?

CPB boosts its PEAK savings goal to $375M by 2028, aiming to offset rising tariffs and strengthen margin resilience.

Zacks Equity Research

Can Campbell's Snacks Business Stabilize After a Gradual Recovery in 2H25?

CPB's snacks business shows early signs of recovery, but sustaining momentum into fiscal 2026 depends on execution and cost control.

Zacks Equity Research

Company News for Sep 4, 2025

Companies In The News Are: M, DLTR, CPB, REVG.

Zacks Equity Research

Campbell's Q4 Earnings Beat Estimates, Organic Sales Drop 3% Y/Y

CPB posts mixed Q4 results as earnings top estimates but sales miss, pressured by weak organic growth.

Zacks Equity Research

Campbell (CPB) Reports Q4 Earnings: What Key Metrics Have to Say

The headline numbers for Campbell (CPB) give insight into how the company performed in the quarter ended July 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Equity Research

Campbell's (CPB) Q4 Earnings Beat Estimates

Campbell (CPB) delivered earnings and revenue surprises of +8.77% and -0.55%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Campbell's Gears Up for Q4 Earnings: Here's What Investors Should Know

CPB gains from Meals & Beverages strength and Sovos integration, but Snacks softness and inflation are likely to weigh on results.

Zacks Equity Research

Campbell (CPB) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Besides Wall Street's top-and-bottom-line estimates for Campbell (CPB), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended July 2025.

Zacks Equity Research

Earnings Preview: Campbell's (CPB) Q4 Earnings Expected to Decline

Campbell (CPB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Is PepsiCo's Frito-Lay Snacks Unit Still the Star Performer?

PEP beats Q2 expectations with pricing power. However, soft volumes and long-term growth questions loom.

Zacks Equity Research

US Foods (USFD) Tops Q2 Earnings Estimates

US Foods (USFD) delivered earnings and revenue surprises of +4.39% and -1.01%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Why Is Campbell (CPB) Down 7.5% Since Last Earnings Report?

Campbell (CPB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Will the Weak Snack Demand Bite Into PepsiCo's Future Momentum?

PEP faces pressure as soft snack demand hits Frito-Lay North America despite strength in global beverage segments.

Zacks Equity Research

Campbell Stock Hits 52-Week Low: Temporary Dip or Deeper Concern?

CPB stock nears a 52-week low as weak snack sales, cost inflation and a muted outlook weigh on investor sentiment.

Zacks Equity Research

Company News for Jun 3, 2025

Companies in The News Are: CPB,SAIC,MRNA,GM